nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—CCR1—urethra—vaginal cancer	0.163	0.163	CbGeAlD
Raltegravir—CCR1—endometrium—vaginal cancer	0.16	0.16	CbGeAlD
Raltegravir—CCR1—mammalian vulva—vaginal cancer	0.155	0.155	CbGeAlD
Raltegravir—CCR1—uterus—vaginal cancer	0.148	0.148	CbGeAlD
Raltegravir—CCR1—female reproductive system—vaginal cancer	0.133	0.133	CbGeAlD
Raltegravir—CCR1—female gonad—vaginal cancer	0.121	0.121	CbGeAlD
Raltegravir—CCR1—vagina—vaginal cancer	0.12	0.12	CbGeAlD
